Conversely, in HCT116 colon cancer cells, PATZ1 can inhibit p53’s transcriptional activity, as evidenced by its interference with p53’s DNA-binding or competition for identical consensus regions observed with CDKN1A and BCC3 [87]. The gene discussed is TP53; the disease is malignant colon neoplasm.